Theraclion SA (TCLIF)

OTCMKTS · Delayed Price · Currency is USD

0.5320

0.00 (0.00%)

At close: Apr 8, 2026

Market Cap	62.19M +34.6%
Revenue (ttm)	765.53K -21.4%
Net Income	-6.68M
EPS	-0.11
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.5320
Previous Close	n/a
Day's Range	0.5320 - 0.5320
52-Week Range	0.5320 - 0.5320
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2026

About Theraclion

Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2004

Employees 36

Stock Exchange OTCMKTS

Ticker Symbol TCLIF

Financial Performance

In 2025, Theraclion's revenue was 652,000, a decrease of -21.35% compared to the previous year's 829,000. Losses were -5.69 million, -1.16% less than in 2024.

Financial numbers in EUR Financial Statements